SNGX News and Press, Soligenix Inc. From 04/15/24

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection PR Newswire Provides MarVax™ Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON...

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection PR Newswire Provides SuVax™ Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON...

Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency PR Newswire Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Stati...

2024-03-15 13:53:01 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Soligenix (NASDAQ: SNGX ) just reported results for the fourth quarter of 2023. Soligenix reported earnings per share of -6 cents. This was above the analyst estimate for ...

2024-03-15 07:35:53 ET More on Soligenix Seeking Alpha’s Quant Rating on Soligenix Historical earnings data for Soligenix Financial information for Soligenix Read the full article on Seeking Alpha For further details see: Soligenix GAAP EPS...

Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results PR Newswire PRINCETON, N.J. , March 15, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and...

Soligenix Announces Formation of Behçet's Disease Medical Advisory Board PR Newswire Phase 2a clinical study of SGX945 in Behçet's Disease initiating in 2024 PRINCETON, N.J. , Feb. 8, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soli...

ORLANDO, FL / ACCESSWIRE / January 26, 2024 / RedChip Companies will air interviews with Soligenix, Inc. (NASDAQ:SNGX) and Mobilicom Limited (NASDAQ:MOB) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, January 27, at 7 p.m. Eastern Time ...

Soligenix to Present at The Microcap Conference PR Newswire PRINCETON, N.J. , Jan. 25, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to tre...

2024-01-16 10:22:55 ET More on Soligenix Soligenix wins FDA nod to conduct trial for rare disease therapy Seeking Alpha’s Quant Rating on Soligenix For further details see: Soligenix files to sell 10.64M shares of common stock, warrants